BSECompany Update6 Aug 2026 · 6 Aug 2026, 09:24 am
Enclosed is disclosure with respect to agreement entered into.
Inventurus Knowledge Solutions Ltd · 544309
✦ AI SummaryFundraise
Inventurus Knowledge Solutions Ltd has entered into a Stock Purchase Agreement with Alpha Square Group Fund IV, LP for the sale of Series A-1 Preferred Shares held by its wholly owned subsidiary, Inventurus Knowledge Solutions, Inc. in Abridge AI Inc. for USD 10,000,175.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Inventurus Knowledge Solutions Ltd - 544309 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Details Of The Stock Purchase Agreement For Sale Of Series A-1 Preferred Shares Held By Inventurus Knowledge Solutions, Inc. In Abridge AI Inc.
Attachments (1)
📄pdf
Download →
48094e46-7aa8-4168-98dd-927d56a8eee3.pdf
View document text
August 06, 2026
BSE Limited National Stock Exchange of India Limited
The Listing Department The Listing Department
Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, G Block,
25th Floor, Dalal Street Bandra Kurla Complex
Fort, Mumbai 400 001 Bandra (East), Mumbai 400051
Maharashtra, India Maharashtra, India
BSE Scrip Code: 544309 NSE Symbol: IKS
Dear Sir/Ma’am,
Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015 - Details of the Stock Purchase Agreement for sale of Series A-1 Preferred Shares held by Inventurus
Knowledge Solutions, Inc. in Abridge AI Inc.
Pursuant to the provisions of Regulations 30 read with Schedule III of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), we hereby inform you that
Inventurus Knowledge Solutions, Inc. ("IKS Inc."), a wholly owned subsidiary of Inventurus Knowledge
Solutions Limited (the "Company"), has entered into a Stock Purchase Agreement ("SPA") dated August 05,
2026, with Alpha Square Group Fund IV, LP (the "Purchaser") for the sale of certain Series A-1 Preferred Shares
of Abridge AI Inc held by IKS Inc.
The relevant disclosures as required under Regulation 30 of the SEBI LODR Regulations and Part A of Schedule
III thereof, read with SEBI Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 (Master Circular for
compliance with the provisions of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 by listed entities) dated January 30, 2026, is enclosed herewith
as Annexure - A.
We request you to take the same on your records
Yours sincerely,
For Inventurus Knowledge Solutions Limited
Sameer Chavan
Company Secretary and Compliance Officer
Membership No. F7211
Encl: As above
Inventurus Knowledge Solutions Limited
Registered Address: 801, Building No. 5, 8th Floor, Mindspace Business Park (SEZ),
Thane-Belapur Road, Airoli, Navi Mumbai – 400708, Thane, Maharashtra, India
Ph.: +91 22 3071 1100 | W: www.ikshealth.com | CIN: L72200MH2006PLC337651
Annexure – A
DISCLOSURE UNDER REGULATION 30 OF THE SEBI LODR REGULATIONS READ WITH SEBI CIRCULAR NO.
HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 DATED JANUARY 30, 2026
Details of the Stock Purchase Agreement for sale of Series A-1 Preferred Shares held by Inventurus
Knowledge Solutions, Inc. in Abridge AI Inc.
S. Particulars Description
1. Name(s) of parties with whom The parties to the Stock Purchase Agreement (“SPA”) are as follows:
the agreement is entered
1. Seller - Inventurus Knowledge Solutions, Inc. (a wholly owned
subsidiary of the Company) (“IKS Inc”) of Inventurus Knowledge
Solutions Limited (“the Company”).
2. Purchaser - Alpha Square Group Fund IV, LP
3. Confirming Party - Abridge AI Inc
2. Purpose of entering into the Monetization/partial divestment of Series A-1 Preferred Shares held by
agreement IKS Inc in Abridge AI Inc
3. Size of agreement USD 10,000,175/-.
4. Shareholding, if any, in the entity
Not applicable.
with whom the agreement is
executed
5. Significant terms of the Sale of 54,055 Series A-1 Preferred Shares for an aggregate
agreement (in brief) special consideration of USD 10,000,175/-.
rights like right to appoint
directors, first right to share
subscription in case of issuance
of shares, right to restrict any
change in capital structure etc.
6. Whether the said parties are None of the parties to the SPA form part of or are related to the
related to promoter/promoter promoters/ promoter group/group companies of the Company.
group/ group companies in any
manner. If yes, nature of
relationship
7. Whether the transaction would No
fall within related party
transactions? If yes, whether the
same is- done at "arms length"
8. In case of issuance of shares to Not Applicable
the parties, details of issue price,
class of shares issued
9. in case of loan agreements, Not Applicable
details of lender/borrower,
Inventurus Knowledge Solutions Limited
Registered Address: 801, Building No. 5, 8th Floor, Mindspace Business Park (SEZ),
Thane-Belapur Road, Airoli, Navi Mumbai – 400708, Thane, Maharashtra, India
Ph.: +91 22 3071 1100 | W: www.ikshealth.com | CIN: L72200MH2006PLC337651
nature of the loan, total amount
of loan granted/taken, total
amount outstanding, date of
execution of the loan
agreement/sanction letter,
details of the security provided
to the lenders / by the
borrowers for such loan or in
case outstanding loans lent to a
party or borrowed from a party
become material on a
cumulative basis
10. Any other disclosures related to Not Applicable
such agreements, viz., details of
nominee on the board of
directors of the listed entity,
potential conflict of interest
arising out of such agreements,
etc.
11. In case of termination or Not Applicable
amendment of agreement,
listed entity shall disclose
additional details to the stock
exchange(s):
i. name of parties to the
agreement;
ii. nature of the agreement;
iii. date of execution of the
agreement;
iv. details of amendment and
impact thereof or reasons of
termination and impact
thereof.
Inventurus Knowledge Solutions Limited
Registered Address: 801, Building No. 5, 8th Floor, Mindspace Business Park (SEZ),
Thane-Belapur Road, Airoli, Navi Mumbai – 400708, Thane, Maharashtra, India
Ph.: +91 22 3071 1100 | W: www.ikshealth.com | CIN: L72200MH2006PLC337651